Arab Drug Company (ADCI) reported a 108% year-on-year (YoY) increase in net profit for the first half (H1) of fiscal year (FY) 2022/2023, according to the company’s unaudited financial income statement filed to the Egyptian Exchange (EGX) on Tuesday.

The company has achieved a net profit after tax of EGP 53.197 million in the six-month period ended December 31st, compared to EGP 49.467 million in H1 FY 2021/2022.

it is worth noting that the company’s net profit after tax grew to EGP 27.695 million in the three-month that ended on September 30th from EGP 25.694 million during the same period a year earlier.

Arab Drug is an Egyptian company engaged in the pharmaceutical sector. The company focuses on manufacturing, packaging, and distributing pharmaceutical products as well as chemical solutions for human and veterinary use.

Copyright © 2022 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (